A Phase 1, Study of BMF-500 in Adults With Acute Leukemia

Recruiting

Phase 1

BMF-500A Phase 1, Study of BMF-500 in Adults With Acute Leukemia

Sponsor:

Biomea Fusion Inc.

Code:

NCT05918692

Conditions

Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMF-500

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Biomea Fusion Inc. on 2025-04-06.